BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23795934)

  • 1. Controlling sources of preanalytical variability in doping samples: challenges and solutions.
    Lippi G; Mattiuzzi C; Banfi G
    Bioanalysis; 2013 Jun; 5(12):1571-82. PubMed ID: 23795934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood venous sample collection: Recommendations overview and a checklist to improve quality.
    Giavarina D; Lippi G
    Clin Biochem; 2017 Jul; 50(10-11):568-573. PubMed ID: 28242283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veterinary medicines and competition animals: the question of medication versus doping control.
    Toutain PL
    Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality standards for sample processing, transportation, and storage in hemostasis testing.
    Adcock Funk DM; Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2012 Sep; 38(6):576-85. PubMed ID: 22706973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preanalytical variables for liquid chromatography-mass spectrometry (LC-MS) analysis of human blood specimens.
    Salvagno GL; Danese E; Lippi G
    Clin Biochem; 2017 Jul; 50(10-11):582-586. PubMed ID: 28433611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality and reliability of routine coagulation testing: can we trust that sample?
    Lippi G; Franchini M; Montagnana M; Salvagno GL; Poli G; Guidi GC
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):513-9. PubMed ID: 16988544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-doping testing at the 2008 European football championship.
    Vouillamoz M; Thom C; Grisdale R; Saugy M; Giraud S; Robinson N; Gmeiner G; Geisendorfer T
    Drug Test Anal; 2009 Nov; 1(11-12):485-93. PubMed ID: 20355163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of human urine doping control samples: II. microbial degradation of steroids.
    Tsivou M; Livadara D; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Anal Biochem; 2009 May; 388(1):146-54. PubMed ID: 19232313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation.
    Thevis M; Geyer H; Sigmund G; Schänzer W
    J Pharm Biomed Anal; 2012 Jan; 57():26-32. PubMed ID: 21955645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doping in sports].
    Jeschke J; Nekola J; Chlumský J
    Cas Lek Cesk; 1999 May; 138(10):291-7. PubMed ID: 10422337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of exogenous and endogenous factors on the quality of the preanalytical stage of laboratory tests (review of literature).
    Piskunov DP; Danilova LA; Pushkin AS; Rukavishnikova SA
    Klin Lab Diagn; 2020 Dec; 65(12):778-784. PubMed ID: 33373510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spanish Preanalytical Quality Monitoring Program (SEQC), an overview of 12 years' experience.
    Llopis MA; Bauça JM; Barba N; Álvarez V; Ventura M; Ibarz M; Gómez-Rioja R; Marzana I; Puente JJ; Segovia M; Martinez D; Alsina MJ
    Clin Chem Lab Med; 2017 Mar; 55(4):530-538. PubMed ID: 27658151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE).
    Lippi G; Banfi G; Church S; Cornes M; De Carli G; Grankvist K; Kristensen GB; Ibarz M; Panteghini M; Plebani M; Nybo M; Smellie S; Zaninotto M; Simundic AM;
    Clin Chem Lab Med; 2015 Feb; 53(3):357-70. PubMed ID: 25490032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of athlete passport parameters during extended storage.
    Ashenden M; Clarke A; Sharpe K; d'Onofrio G; Plowman J; Gore CJ
    Int J Lab Hematol; 2013 Apr; 35(2):183-92. PubMed ID: 23067319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preanalytical aspects and sample quality assessment in metabolomics studies of human blood.
    Yin P; Peter A; Franken H; Zhao X; Neukamm SS; Rosenbaum L; Lucio M; Zell A; Häring HU; Xu G; Lehmann R
    Clin Chem; 2013 May; 59(5):833-45. PubMed ID: 23386698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preanalytical challenges - time for solutions.
    Lippi G; Betsou F; Cadamuro J; Cornes M; Fleischhacker M; Fruekilde P; Neumaier M; Nybo M; Padoan A; Plebani M; Sciacovelli L; Vermeersch P; von Meyer A; Simundic AM;
    Clin Chem Lab Med; 2019 Jun; 57(7):974-981. PubMed ID: 30710481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present situation in preanalytical sample care--from the results of a questionnaire survey in Fukushima Prefecture].
    Kanno T
    Rinsho Byori; 1991 Jan; 39(1):43-5. PubMed ID: 2008039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence flow cytometer to determine urine particle reference intervals in doping control samples.
    Robinson N; Sottas PE; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):95-100. PubMed ID: 21889276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the tourniquet time on hematological testing for antidoping purposes.
    Lippi G; Salvagno GL; Solero GP; Guidi GC
    Int J Sports Med; 2006 May; 27(5):359-62. PubMed ID: 16729374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues of testing for hGH: collection.
    Uryasz F
    Drug Test Anal; 2009 Sep; 1(9-10):437-8. PubMed ID: 20355227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.